Antigen Presentation Loss

Antigen Presentation Loss is a molecular mechanism in cancer immunology whereby tumor cells downregulate major histocompatibility complex class I molecules, thereby impairing the recognition and targeting of tumor antigens by cytotoxic T cells during metastatic progression.

146

Publications

15.3K

Citations

1.1K

Authors

379

Institutions

Publications per year

2017–2026

44

Authors

1.1K

  1. SF
    Soldano Ferrone

    Massachusetts General Hospital, United States

    8 publications · 1.5K citations

    8

    h-index

  2. FG
    Federico Garrido

    Hospital Universitario Virgen de las Nieves, Spain

    6 publications · 458 citations

    6

    h-index

  3. FR
    Francisco Ruiz‐Cabello

    Hospital Universitario Virgen de las Nieves, Spain

    5 publications · 418 citations

    5

    h-index

  4. BS
    Barbara Seliger

    Martin Luther University Halle-Wittenberg, Germany

    5 publications · 587 citations

    5

    h-index

  5. AP
    Annette Paschen

    Essen University Hospital, Germany

    4 publications · 242 citations

    4

    h-index

1–5 of 1.1K

Venues

  1. PubMed

    Repository · 11 publications · 803 citations

    11

    h-index

  2. The Journal of Immunology

    JI · 8 publications · 656 citations

    8

    h-index

  3. Nature Communications

    6 publications · 498 citations

    6

    h-index

  4. International Journal of Cancer

    6 publications · 339 citations

    6

    h-index

  5. British Journal of Cancer

    BJC · 5 publications · 469 citations

    5

    h-index

1–5